AU2517095A - Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions - Google Patents

Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions

Info

Publication number
AU2517095A
AU2517095A AU25170/95A AU2517095A AU2517095A AU 2517095 A AU2517095 A AU 2517095A AU 25170/95 A AU25170/95 A AU 25170/95A AU 2517095 A AU2517095 A AU 2517095A AU 2517095 A AU2517095 A AU 2517095A
Authority
AU
Australia
Prior art keywords
solutions
aryl
gelatin capsules
soft gelatin
capsules containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25170/95A
Inventor
Rickey S Shelley
Youching Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US247028 priority Critical
Priority to US24702894A priority
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Priority to PCT/US1995/006183 priority patent/WO1995031979A1/en
Publication of AU2517095A publication Critical patent/AU2517095A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
AU25170/95A 1994-05-19 1995-05-19 Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions Abandoned AU2517095A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US247028 1981-03-24
US24702894A true 1994-05-19 1994-05-19
PCT/US1995/006183 WO1995031979A1 (en) 1994-05-19 1995-05-19 Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions

Publications (1)

Publication Number Publication Date
AU2517095A true AU2517095A (en) 1995-12-18

Family

ID=22933249

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25170/95A Abandoned AU2517095A (en) 1994-05-19 1995-05-19 Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions

Country Status (2)

Country Link
AU (1) AU2517095A (en)
WO (1) WO1995031979A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
KR20040015746A (en) 2001-06-21 2004-02-19 화이자 프로덕츠 인크. Self-Emulsifying Formulations of Cholesteryl Ester Transfer Protein Inhibitors
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
AU2005277208B2 (en) 2004-08-20 2011-11-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
DK2322180T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Diketopiperazinsalte for drug delivery
US20070053868A1 (en) * 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
KR20120060245A (en) 2005-09-14 2012-06-11 맨카인드 코포레이션 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
JP5599975B2 (en) 2006-02-22 2014-10-01 マンカインド コーポレイション Method for improving the formulation properties of the fine particles containing diketopiperazine and an active agent
DK2570147T3 (en) 2008-06-13 2018-01-29 Mannkind Corp Dry powder inhaler and system for drug administration
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
RU2470681C2 (en) 2008-06-20 2012-12-27 Маннкайнд Корпорейшн Interactive system and method for real-time force profiling in inhalation
TWI614024B (en) 2008-08-11 2018-02-11 Mannkind Corp Use of ultrarapid acting insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
DK2405963T3 (en) 2009-03-11 2013-12-16 Mannkind Corp An apparatus, system and method for measuring resistance in an inhaler
KR20190090092A (en) 2009-06-12 2019-07-31 맨카인드 코포레이션 Diketopiperazine microparticles with defined specific surface areas
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
AU2011271097B2 (en) 2010-06-21 2014-11-27 Mannkind Corporation Dry powder drug delivery system and methods
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
CA2918369A1 (en) 2013-07-18 2015-01-22 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3500103C2 (en) * 1985-01-04 1987-01-22 R.P. Scherer Gmbh, 6930 Eberbach, De
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5059626A (en) * 1988-07-25 1991-10-22 Applied Analytical Industries, Inc. Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
US5110606A (en) * 1990-11-13 1992-05-05 Affinity Biotech, Inc. Non-aqueous microemulsions for drug delivery
DK0563112T3 (en) * 1990-12-18 1995-04-10 Merrell Dow Pharma Probucol-containing medicament having enhanced bioavailability
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
WO1995031979A1 (en) 1995-11-30

Similar Documents

Publication Publication Date Title
AU692484B2 (en) 1N-alkyl-N-arylpyrimidinamines and derivatives thereof
AU644399B2 (en) Proteins and nucleic acids
AU670488B2 (en) Vinylene-azaindole derivatives and process for their preparation
AU699223B2 (en) Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans
AU680812B2 (en) Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
AU678650C (en) Pharmaceutical emulsion
AU650504B2 (en) Microcapsules and microencapsulation process
AU2476195A (en) Continuous method of grinding pharmaceutical substances
ZA9601243B (en) Benzazepine-, benzoxazepine- and benzothiazepine-N-Acetic acid derivatives and processes for their preparation and medicaments containing these compounds
AU5141390A (en) Film-forming emulsion containing iodine and methods of use
PL307159A1 (en) Pharmaceutical application form of clyndamycin prolonged release and method of obtaining same
PH27592A (en) Imidazolyl-alkenoic acids and its method of use
AU6222086A (en) Gelatine capsules and process for their manufacture
PL178135B1 (en) Novel pakliaxel derivatives and pharmaceutical agent
EP0776011A3 (en) Magnetic memory and method therefor
AU3368695A (en) Capillary electrophoretic detection of nucleic acids
PL313343A1 (en) Method of separating solid substance from liquid one
AU5094899A (en) Method and apparatus for sensing the state of an electrophoretic display
IL128118D0 (en) Modified amino acids medicaments containing these compounds and processes for their preparation
AU7299194A (en) Quinolone carboxylic acid derivatives and pharmaceutical formulations containing them
AU2984092A (en) Reversible direction capsule chemistry sample liquid analysis system and method
IL108633A (en) Hypolipidaemic benzothiazepine derivatives their preparation and pharmaceutical compositions containing them
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU3543689A (en) Substrate examining apparatus and method of operating same
AU8735191A (en) Preparation of polyhydroxy fatty acid amides in the presence of solvents